Basic Information
| LncRNA/CircRNA Name | CUDR |
| Synonyms | UCA1, CUDR, LINC00178, NCRNA00178, UCAT1, onco-lncRNA-36 |
| Region | GRCh38_19:15828206-15836326 |
| Ensemble | ENSG00000214049 |
| Refseq | NR_015379 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR etc. |
| Sample | cell line (KYSE32-R) |
| Expression Pattern | up-regulated |
| Function Description | We observed that three lncRNAs, MALAT1, H19, and CUDR, could be clinically useful as biomarkers for LC-MPE diagnosis. Moreover, the combination of MALAT3 and CEA provided higher sensitivity and accuracy in predicting LC-MPE than CEA alone. |
| Pubmed ID | 29731641 |
| Year | 2018 |
| Title | Combination of long noncoding RNA MALAT3 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer. |
External Links
| Links for CUDR | GenBank HGNC NONCODE |
| Links for lung cancer | OMIM COSMIC |